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Abstract
Natural killer T (NKT) cells are a subset of T lymphocytes with potent immunoregulatory properties. Recognition of self-
antigens presented by CD1d molecules is an important route of NKT cell activation; however, the molecular identity of
specific autoantigens that stimulate human NKT cells remains unclear. Here, we have analyzed human NKT cell recognition
of CD1d cellular ligands. The most clearly antigenic species was lyso-phosphatidylcholine (LPC). Diacylated
phosphatidylcholine and lyso-phosphoglycerols differing in the chemistry of the head group stimulated only weak
responses from human NKT cells. However, lyso-sphingomyelin, which shares the phosphocholine head group of LPC, also
activated NKT cells. Antigen-presenting cells pulsed with LPC were capable of stimulating increased cytokine responses by
NKT cell clones and by freshly isolated peripheral blood lymphocytes. These results demonstrate that human NKT cells
recognize cholinated lyso-phospholipids as antigens presented by CD1d. Since these lyso-phospholipids serve as lipid
messengers in normal physiological processes and are present at elevated levels during inflammatory responses, these
findings point to a novel link between NKT cells and cellular signaling pathways that are associated with human disease
pathophysiology.
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Introduction
Natural killer T (NKT) cells are a unique subpopulation of T
lymphocytes that display innate-like characteristics and can
potently modulate adaptive immune responses [1,2]. They are
among the first cells to respond during microbial infections and
produce a wide variety of cytokines that have multiple effects on
other immune cells [3,4]. NKT cells are characterized by a
restricted T cell receptor (TCR) usage in which the TCRa chain is
invariant, and the TCRb chains show more limited variability
than those of classical T lymphocytes. The T cell receptors of
NKT cells are specific for a nonclassical antigen-presenting
molecule called CD1d that presents lipids and glycolipids. One
of the most remarkable features of NKT cells is the source of the
antigens they recognize. Unlike classical MHC-restricted T cells,
which are selected for recognition of non–self compounds, NKT
cells have been found to recognize both self and foreign molecules
[2,3]. Thus, NKT cells become activated in vivo even when there
is no external challenge, and this property may underlie many of
their immunoregulatory effects as well as their rapid activation
during infection [2,5].
Based on their restricted TCR usage, it has been proposed that
NKT cells recognize a conserved set of antigens. Consistent with
this, NKT cells have been found to share recognition of a class of
microbial lipids in which a galactose sugar is attached in an a-
anomeric configuration to a sphingolipid or a diacylglycerol [6–8].
Recognition of this type of glycolipid appears to be conferred by
an evolutionarily conserved antigen recognition ‘‘hotspot’’ within
the T cell receptors of NKT cells [9–11]. It remains unclear
whether the part of the TCR that varies from NKT cell to NKT
cell confers additional individual antigen recognition properties;
however, a number of reports have documented antigen-specific
responses that are confined to subsets of the NKT cell population,
suggesting that this may indeed be the case [12–14].
The molecular identity of the self-antigens responsible for
endogenously activating NKT cells, and how these antigens
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autoreactive pathology, are major unresolved mysteries. A series of
studies has indicated that the self-antigens recognized by murine
NKT cells are loaded into CD1d molecules within intracellular
endosomal vesicles and require specialized processing steps that
take place at these sites. Mutated CD1d molecules that do not
traffic through the endosomal vesicular system fail to stimulate
CD1d-dependent autoreactive responses by murine NKT cells
and are not able to positively select NKT cells in vivo [15,16].
Additionally, murine NKT cells show reduced responses to self-
antigens if normal endosomal functioning is inhibited, for
example, by the addition of pH-altering drugs or when
lysosome-resident enzymes are genetically deficient [17,18]. A
glycolipid called isoglobotrihexosyl ceramide (iGb3) that is
generated in lysosomal compartments through glycosidic cleavage
of the mature tetra-glycosylated form has been identified as a self-
antigen recognized by murine NKT cells [19]. However, this
glycolipid is not required for the development and function of
murine NKT cells in vivo, suggesting that other as yet unidentified
compounds also function as NKT cell self-antigens [20].
In contrast to the murine system, the self-antigen responses of
human NKT cells do not require lysosomal processes [21,22].
Mutated human CD1d molecules that do not traffic through the
endosomal system stimulated normal autoreactive responses by
human NKT cell clones, and drugs that alter lysosomal pH also
had no deleterious effect [22]. Similarly, antigen-presenting cells
(APCs) that are genetically deficient in lysosomal lipid transfer
proteins stimulated normal self-antigen responses by human NKT
cells [21]. Moreover, although the iGb3 glycolipid is antigenic for
a fraction of the human NKT cell subpopulation [19,23], it is not
clear that this is a self-antigen for human NKT cells, since current
data suggest that the iGb3 molecule is not produced in humans
due to the lack of functional genes for galactosyl transferase
enzymes that are required for its biosynthesis [24]. These data,
demonstrating disparity between the human and murine systems,
suggest there may be significant differences in the nature of the
self-antigens that regulate human and murine NKT cell responses.
This potentially clinically important point will not be clarified until
there is a molecular understanding of the CD1d ligands
recognized by NKT cells of each species. Here, we have analyzed
the responses of human NKT cells to lipids found within the ligand
pool of secreted human CD1d molecules.
Results
To identify self-antigens recognized by human NKT cells, we
tested their responses to synthetic preparations of compounds that
were identified in a pool of ligands eluted from human CD1d
molecules [25]. Lipids were pulsed onto plate-bound recombinant
human CD1d-Fc fusion protein and tested for their ability to
stimulate cytokine secretion by a panel of human NKT cell clones.
We have found from previous analyses that the CD1d-Fc fusion
protein, which is produced in a hamster cell line, does not
stimulate significant responses from our NKT cells unless an
antigenic lipid is added [23]. Hence, because there is little or no
detectable reactivity to CD1d ligands that may be endogenously
present in the recombinant molecules, this assay provides a means
of assessing NKT cell responses to added ligands, even if they are
relatively weak agonists [26].
Recognition of LPC
Figure 1A shows a summary of responses by human NKT cell
clones to glycerophospholipids and sphingolipids found within a
pool of lipid ligands eluted from human CD1d molecules [25].
Ligand species were selected so as to include representative
diacylated phospholipids (phosphatidylcholine, PC; phosphatidyl-
ethanolamine, PE; phosphatidylinositol, PI; and phosphatidylgly-
cerol, PG), a tetra-acylated cardiolipin (CL) species, monoacylated
lyso-phospholipids (lyso-phosphatidylcholine, LPC; lyso-phospha-
tidylethanolamine, LPE; lyso-phosphatidylglycerol, LPG; and lyso-
phosphatidic acid, LPA), and the two most abundant sphingolipids
(sphingomyelin, SM; and the ganglioside GM3). As a positive
control, the CD1d-Fc molecules were pulsed with a form of the
prototypical NKT cell antigen a-galactosylceramide (a-GalCer)
that contains a 20-carbon fatty acyl chain with two unsaturations
(C20:2) and is known to load particularly well into recombinant
CD1d molecules in solution [27]. Since natural ligands generally
have been found to stimulate weaker responses from NKT cells
than a-GalCer, as another control, we also assessed NKT cell
responses to a truncated form of a-GalCer called ‘‘OCH’’ that has
been shown to be a weaker agonist for human NKT cells [26,28].
Of the species tested from the CD1d ligand pool, LPC elicited the
strongest NKT cell responses (Figure 1A). The NKT cell responses
to LPC were generally 10- to 100-fold less than their responses to
the C20:2 analog of a-GalCer and appeared similar to those
induced by OCH (Figure 1A), suggesting that LPC is a weak to
moderate agonist.
Clonal Differences in LPC Recognition
Variation in the strength of the responses to LPC appeared to
be largely due to reactivity differences among the NKT clones.
Individual NKT cell clones were quite reproducible in their
responses to LPC; some clones consistently showed strong
responses, some regularly showed moderate or weak responses,
and some repeatedly showed little or no detectable response
(Figure 1B). The strength of individual NKT clone responses to
LPC did not correlate with their responses to the C20:2 analog of
a-GalCer (Figure 1B), suggesting that the LPC reactivity
differences were not simply due to differing activation thresholds.
Titrating the concentration of LPC used to prepulse the CD1d-Fc
fusion protein yielded similar dose-response curves for all of the
NKT cell clones. Significant responses above background were
Author Summary
A central tenet of immunology is that cellular responses
that protect us from pathogens result from molecular
recognition of foreign compounds (antigens). The role of
self-antigens in immune activation is less clear. We show
here that an endogenous lipid called lyso-phosphatidyl-
choline (LPC) is recognized as an antigen by a subpopu-
lation of human T lymphocytes, called natural killer T (NKT)
cells, and specifically by the best-studied subgroup of
these cells known as invariant NKT (iNKT) cells. NKT cells
have attracted the interest of immunologists because they
can potently influence the outcome of diverse immune
responses; for example, they can promote bacterial
clearance and tumor rejection, and they can also quell
autoimmune disease pathology. Previous studies indicated
that NKT cells are activated by self-antigens, but the
identity of the relevant compounds remained unclear. Our
finding that LPC is a self-antigen for iNKT cells suggests
that these lymphocytes are attuned to highly conserved
lipid signaling pathways that are fundamental to normal
physiological processes and are markedly up-regulated
during inflammation. Thus, these results provide a new
molecular basis for understanding how iNKT cells contrib-
ute to a wide variety of immune responses.
NKT Cell Recognition of Self-Antigens
PLoS Biology | www.plosbiology.org 2 October 2009 | Volume 7 | Issue 10 | e1000228Figure 1. NKT cell recognition of LPC. (A) Human NKT cell clones were tested for cytokine secretion in response to immobilized recombinant
CD1d molecules that were pulsed with lipid species that were found among the ligands eluted from human CD1d molecules [25]. Two a-
galactosylsphingolipids (a-GSL OCH and C20:2) were tested in parallel as controls. Each dot represents an individual NKT cell clone’s response to the
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with a peak at about 25 mM (Figure 1C). Notably, NKT cell
responses were consistently diminished or absent at higher LPC
pulse concentrations (Figure 1C).
To confirm that the NKT cell responses were due to recognition
of LPC and not to a contaminant in the synthetic preparations of
this compound, we tested LPC purified from chicken eggs. Dose-
response curves to this LPC preparation, comprising a mixture of
LPC species differing in their hydrocarbon chain lengths and
double bonds, were similar to those for the synthetic LPC
(Figure 1D). Thus, both synthesized and natural LPC preparations
were recognized by the NKT cell clones, whereas synthesized
preparations of related phospholipids were not.
To further investigate NKT cell recognition of LPC, we sorted a
polyclonal population of NKT cells from the peripheral blood of a
healthy volunteer donor using fluorescently labeled a-GalCer–
loaded CD1d tetramers and expanded the cells in vitro for a short
time (less than 1 mo) by stimulating them with PHA and IL-2 in
the presence of irradiated autologous mononuclear cells. The
resulting population of cells showed uniformly positive staining
using an anti-CD3 antibody and a-GalCer–loaded CD1d
tetramer, and contained approximately equal fractions of CD4
+
and CD4
2 cells (Figure 1E, top panels). The expanded polyclonal
NKT cells showed a detectable cytokine response to plate-bound
CD1d-Fc molecules pulsed with LPC and also responded to the
C20:2 analog of a-GalCer (Figure 1E, bottom panels).
Analysis of Other Ligand Species
Our screening of NKT cell lipid recognition showed occasional
weak responses to other lipids identified within the CD1d ligand
pool (Figure 1A). Therefore, we evaluated the NKT cell responses
to these CD1d ligands using titrated doses of lipid. NKT cell
clones that responded to LPC generally showed little or no
recognition of other lyso-phospholipids, suggesting molecular
specificity for LPC. For example, LPA, which is identical to
LPC except for the absence of the choline head group, induced
little or no NKT cell activation above background (Figure 2A).
Diacylated PC sometimes stimulated very weak positive responses,
but in most cases, there was no significant NKT cell activation
from this lipid (Figure 2B), suggesting that the lyso- form contains
antigenic features not present in the diacylated lipid.
We had previously identified a human NKT cell clone that
consistently demonstrated specific responses to PI and PE,
although other human NKT cell clones tested in parallel showed
little or no recognition of these lipids [23]. In the current analysis,
we found that PI was capable of eliciting weak responses from
some NKT cell clones, but in general, this lipid failed to show
stimulatory effects for the clones tested here (Figure 2C). PE only
rarely elicited positive responses from the panel of NKT clones
(Figure 1A, and unpublished data). We also failed to detect positive
responses to plasmalogen forms of PE and PC (unpublished data).
Weak but detectable NKT cell responses were sometimes observed
to a purified preparation of the GM3 ganglioside, although in most
cases, the results for this lipid were also negative (Figure 2D).
Notably, a human NKT cell clone (J3N.4), from which we
previously reproducibly observed positive responses to iGb3 [23],
did not respond to the structurally related compound GM3
(Figure 2D). Sphingomyelin also generally stimulated no detect-
able response from the NKT cell clones (Figure 1A, and
unpublished data). Thus, LPC was unique among the ligand
species tested here in the strength, consistency, and dose-
dependence of the NKT cell responses it elicited.
Presentation of LPC by CD1d
Lyso-phospholipids are known to be highly bioactive molecules
that can signal through G-protein–coupled receptors; therefore, it
was possible that the responses we observed might be due to direct
stimulation of NKT cells, rather than via TCR-mediated antigen
recognition. To address this possibility, we performed a number of
controls to confirm that the observed NKT cell responses were due
to recognition of LPC in the context of CD1d. NKT cells that
were incubated directly with LPC in the absence of CD1d
molecules showed no detectable cytokine secretion, and similarly,
there was no response to plate-bound negative control antibody
that was prepulsed with LPC (Figure 3A). NKT cell responses to
LPC-pulsed CD1d-Fc molecules were specifically blocked by an
anti-CD1d antibody (Figure 3B). Additionally, the NKT cells did
not respond to CD1c-Fc molecules that were prepulsed with LPC
(Figure 3C), although we found that CD1c-Fc and CD1d-Fc
molecules showed similar binding of a biotinylated lyso-phospho-
lipid (Figure 3D). Together, these results demonstrate that NKT
cell responses to LPC require presentation by CD1d molecules.
Molecular Specificity of Recognition
In our initial screening of lyso-phospholipids found in a pool of
eluted CD1d ligands [25], LPC was the only species that
consistently stimulated cytokine secretion from most of the NKT
cell clones (Figure 1A). Since the lipid tails of all of the lyso-
phospholipids tested in this analysis were identical (i.e., C18:1), this
suggests that NKT cell recognition is dependent on chemical
features of the head group. To investigate this further, we tested
the ability of LPC-reactive NKT cells to respond to lyso-
sphingomyelin (LSM), a structurally related compound that was
not found in the CD1d ligand pool. LPC and LSM can be
generated by similar enzymatic cleavage of the diacylated
phospholipids phosphatidylcholine (PC) and sphingomyelin (SM),
indicated lipid, normalized by its response to vehicle alone. The results are compiled from analyses of 12 NKT cell clones. The control lipid a-GSL C20:2
was used at 0.6–1.2 mM; all other lipids were tested at concentrations of 20–75 mM. The horizontal line indicates the mean of the responses to each
lipid. (B) Clonal variation in NKT cell responses to LPC. Ten different NKT cell clones were tested as described above for responses to LPC or a positive
control antigen (C20:2 a-GSL). The plot shows the mean and standard deviation from two to four independent analyses of each clone, with the data
expressed as the fold increase in cytokine secretion stimulated by lipid-pulsed CD1d as compared to vehicle-treated CD1d. (C) Cytokine secretion by
four different NKT cell clones in response to CD1d molecules pulsed with the indicated concentrations of a synthetic preparation of C18:1 LPC.
Inverted triangles show the cytokine secretion by each clone in the absence of recombinant CD1d molecules (shaded triangles), or to recombinant
CD1d molecules treated with vehicle alone (open triangles). Results shown are from one representative experiment for each clone; similar dose-
response curves were observed for each clone in two to four independent assays. (D) Dose-response curves for NKT cell clones to CD1d molecules
pulsed with a preparation of LPC purified from chicken eggs. Similar results were observed in four independent assays. (E) Polyclonal NKT cells were
isolated from human blood by magnetic sorting of cells labeled with a CD1d-Fc fusion protein loaded with the C20:2 a-GSL, and expanded in culture
for 3–4 wk. Top panels show flow cytometric analysis of the expanded cells using a-GSL–loaded CD1d tetramer, anti-CD3, and anti-CD4 antibodies.
Lower panels show cytokine secretion by the expanded NKT cells in response to plate-bound CD1d molecules pulsed with LPC, C20:2 a-GSL, or
vehicle alone. Error bars in (B–E) indicate the standard deviation (SD). CL, cardiolipin; GM3, monosialoganglioside GM3; GM-CSF, granulocyte
macrophage colony-stimulating factor; LPA, lyso-phosphatidic acid; LPC, lyso-phosphatidylcholine; LPE, lyso-phosphatidylethanolamine; LPG, lyso-
phosphatidylglycerol; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; SM, sphingomyelin.
doi:10.1371/journal.pbio.1000228.g001
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PLoS Biology | www.plosbiology.org 4 October 2009 | Volume 7 | Issue 10 | e1000228Figure 2. NKT cells show little or no response to other cellular lipids. (A) Representative examples of NKT cell clone responses to
immobilized CD1d molecules pulsed with synthetic C18:1 LPA; (B) synthetic C18:1/C18:1 PC, (C) synthetic C18:1/C18:1 PI, and (D) purified ganglioside
GM3. The plots show the means and standard deviations of three to four replicates.
doi:10.1371/journal.pbio.1000228.g002
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lyso- species that contain a choline head group linked by a
phosphate ester to a single hydrocarbon tail (Figure 4A). NKT cell
clones that recognized LPC consistently also showed responses to
CD1d-Fc molecules that were prepulsed with LSM, although
higher molar concentrations of LSM were required to stimulate
responses (Figure 4B). In contrast, there was typically no
detectable response to SM, the diacylated form (Figure 4C).
Sphingosine 1-phosphate, a lyso- species lacking the choline head
group, stimulated little or no response from the NKT cells
(Figure 4D). Hence, NKT cell responses were specific for lyso-
phospholipids containing a choline head group.
Effect of Abundant Ligands on CD1d Antigen Loading
Whereas lipids that appear to be abundant cellular ligands of
human CD1d, such as SM, PC, PE, PI, CL, or GM3 [25,29,30],
showed little or no antigenicity in this analysis, it is nevertheless
possible that they play an important role in the CD1d antigen-
Figure 3. Responses to LPC are due to CD1d-mediated presentation. (A) NKT cell clones J24L.17 and J24N.22 were incubated directly with
20 mM of LPC (far left), with immobilized negative control antibody pulsed with 20 mM of LPC (second from left), immobilized CD1d-Fc molecules
pulsed with 20 mM of LPC (second from right), or with immobilized CD1d-Fc pulsed with vehicle (far right), and cytokine secretion was quantitated by
ELISA. Similar results were observed in four independent assays. (B) Responses of NKT cell clones JC2.7 and J24L.17 to CD1d molecules pulsed with
LPC were blocked by inclusion of an anti-CD1d antibody but not an isotype-matched negative control antibody. Similar results were observed in two
independent assays. (C) NKT cells respond to LPC-pulsed CD1d molecules, but not to the related isoform CD1c. The plot shows one representative
experiment out of two, using clone J3N.5. Similar results were observed with three other NKT cell clones. (D) Biotinylated C18:1 LPE binds similarly to
CD1d and CD1c molecules. Similar results were observed in three independent experiments.
doi:10.1371/journal.pbio.1000228.g003
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antigenic lipids to load into CD1d molecules. We therefore
investigated whether binding of these lipids to CD1d could block
the subsequent presentation of an antigenic glycolipid. Recombi-
nant CD1d-Fc molecules were preincubated with diacylated
phospholipids or sphingolipids. The recombinant CD1d-Fc was
then washed and incubated with a saturating concentration of the
C20:2 analog of a-GalCer and tested for the ability to stimulate
cytokine secretion by NKT cell clones. Pretreatment with several
of the lipids, including PA, PC, PE, CL, and GM3, consistently
resulted in almost complete blocking of the response to the C20:2
antigen (Figure 5A). In contrast, pretreatment with PG, PI, or SM
resulted in only partial blocking of C20:2 (Figure 5A). These
results suggest that a fraction of the CD1d molecules exiting the
secretory pathway (e.g., those containing PG, PI, or SM) may be
receptive to binding extracellular diacylated lipids such as C20:2 at
the cell surface.
We next investigated the ability of lyso-phospholipids to bind to
CD1d molecules containing cellular ligands. We have found that
we can readily detect specific association of biotinylated LPE with
recombinant CD1d-Fc molecules (Figure 3D). However, it is not
clear whether the CD1d-Fc fusion proteins used in these
Figure 4. Molecular specificity of NKT cell recognition. (A) Chemical structures of di-C18:1 PC and SM, and their lyso derivatives LPC and LSM.
(B) Response of NKT cell clone J3N.5 to CD1d molecules pulsed with the indicated concentrations of LPC or LSM. One representative experiment out
of five is shown. Similar results were observed with two other NKT cell clones. (C) Only the lyso- form of sphingomyelin appears markedly antigenic
for NKT cells. The results shown are from one representative experiment out of two using clone J3N.5. Similar results were observed with two other
NKT cell clones. (D) Sphingosine-1-phosphate (S1P), which is identical to LSM except that it lacks the choline head group, was not recognized. Results
shown are from one representative experiment out of three using clone Jc2.7. Similar results were observed with two other NKT cell clones.
doi:10.1371/journal.pbio.1000228.g004
NKT Cell Recognition of Self-Antigens
PLoS Biology | www.plosbiology.org 7 October 2009 | Volume 7 | Issue 10 | e1000228experiments contain endogenous lipids, and if they do, whether
these modulate the binding of exogenously added lipids.
Therefore, we investigated the binding of biotinylated LPE to
purified CD1d-b2m heterodimers that were produced in a human
lymphoblastoid cell line, and for which the bound ligands have
recently been characterized as a mixture of phospholipids and
sphingolipids [25]. Although the signal was much lower than that
observed for the CD1d-Fc fusion protein, the purified CD1d-b2m
molecules also yielded a biotin signal that was significantly above
the background, indicating the presence of bound LPE (Figure 5B).
These results indicate that lyso-phospholipids can bind to CD1d
molecules containing a complex mixture of cellular lipids.
To further investigate, we tested whether lyso-phospholipids can
cause the dissociation of diacylated lipids from CD1d molecules.
Recombinant human CD1d molecules produced in insectcells have
a uniform charge distribution and can be visualized as a single
majorband onanativeisoelectricfocusing(IEF)gel(Figure 5C,lane
1). When the CD1d molecules are loaded with a charged lipid such
as the trisialoganglioside GT1b, the band shifts due to the acidic
charge of the bound lipid (Figure 5C, lanes 2 and 3). Binding of a
neutral lipid (e.g., a-GalCer) to the CD1d-GT1b complex replaces
the bound GT1b and is therefore associated with loss of the acidic
charge (Figure 5C, lane 4). We found that addition of a 3-fold molar
excess of either LPC or LPE to the CD1d-GT1b complex resulted
in dissociation of 70%–80% of the bound GT1b, as assessed by the
reduced intensity of the acidic band and the increased intensity of
the basic band (Figure 5C, lanes 5 and 6). Titrating the
concentration of lyso-phospholipid that was added to the CD1d-
GT1b complex demonstrated that even a 1:1 molar ratio of lyso-
phospholipid to CD1d was sufficient to induce dissociation of
approximately 30% of the bound GT1b (Figure 5D, lane 2), with
nearly complete GT1b dissociation observed at molar ratios of 5:1
or higher (Figure 5D, lanes 3–6). These results demonstrate that
lyso-phospholipid loading into CD1d molecules is not prevented by
previously bound diacylated lipids.
Cell Surface Presentation of LPC
Previous studies have indicated that endosomal trafficking of
CD1d is important for efficient presentation of certain exogenous
lipids, such as a-GalCer, apparentlybecause loading of a-GalCer into
CD1d molecules occurs much more efficiently in endosomal vesicles
[22,31]. We therefore investigated the role of CD1d endosomal
trafficking for presentation of exogenous LPC by APCs. As observed
previously [22], human lymphoblastoid cell lines transfected with
cytoplasmic tail-deleted CD1d molecules that lack the amino acid
motif required for reinternalization from the cell surface show
reduced a-GalCer–dependent NKT cell responses compared with
transfectants expressing wild-type CD1d (Figure 6A). However, wild-
Figure 5. Effect of bound lipids on CD1d antigen loading. (A) Immobilized CD1d molecules were preincubated with the indicated lipids or
treated with vehicle alone for 24 h. Unbound lipids were washed away, and the CD1d molecules were incubated with the a-GSL C20:2 for 24 h, then
tested for the ability to stimulate NKT cell cytokine secretion. Percent inhibition was calculated by comparing NKT cell cytokine secretion in response
to C20:2 pulsed onto CD1d molecules pretreated with lipid compared to CD1d pretreated with vehicle alone. The plot shows means and standard
deviations of results compiled from seven independent experiments. (B) Biotinylated LPE (15 mM) was incubated with CD1d-Fc fusion protein or with
secreted CD1d-b2m heterodimers that contain a mixture of bound ligands [25]. The samples were then incubated on plates coated with an anti-CD1d
mAb (filled bars) or with an isotype-matched negative control mAb (open bars), and bound LPE was detected using a streptavidin-enzyme conjugate.
OD450nm, optical density at 450 nm. (C) Native isoelectric focusing (IEF) analysis of lyso-phospholipid binding to recombinant CD1d molecules.
Purified native CD1d molecules were mock-treated (lane 1), or preloaded with the trisialoganglioside GT1b (lanes 2–6), then incubated in solution
with free lipids and separated by electrophoresis according to charge. Lane 3 shows GT1b-CD1d incubated with additional GT1b; lane 4 shows GT1b-
CD1d incubated with a 4.5-fold molar excess of a-GalCer; lane 5 shows GT1b-CD1d incubated with a 3-fold molar excess of LPC; and lane 6 shows
GT1b-CD1d incubated with a 3-fold molar excess of LPE. (D) Titration of the amount of lyso-phospholipid required to displace bound GT1b. Lane 1
shows GT1b-CD1d incubated in buffer with no LPE; lanes 2–6 show GT1b-CD1d incubated with the following molar ratios of LPE: lane 2=1:1, lane
3=1:2, lane 4=1:3, lane 5=1:5, and lane 6=1:9.
doi:10.1371/journal.pbio.1000228.g005
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PLoS Biology | www.plosbiology.org 8 October 2009 | Volume 7 | Issue 10 | e1000228Figure 6. Presentation of LPC by cell surface CD1d. (A) Human lymphoblastoid cell lines transfected with either wild-type (WT) or cytoplasmic
tail-deleted (TD) human CD1d molecules, or the untransfected parental cells (i.e., CD1d-negative) were tested for the ability to stimulate cytokine
secretion by human NKT cell clones. The cells were pulsed with 7.5 nM a-GalCer (aGC) or mock treated, then washed and incubated with NKT cell
clones. Culture supernatants were collected after 24 h and assayed for GM-CSF (a cytokine produced by the NKT cells) using a standardized ELISA.
The plot shows one representative experiment out of three, using clone Jc2.7. Similar results were observed with three other NKT cell clones. The
asterisk indicates signal that was below the limit of detection. (B) Transfectants expressing wild-type or tail-deleted CD1d were pulsed with 1–10 mM
LPC or 7.5 nM a-GalCer, and used to stimulate human NKT cell clones. Each dot represents an independent analysis, with the data expressed as the
amount of cytokine secreted in response to antigen-pulsed APCs normalized by the response to mock-treated APCs. The horizontal line indicates the
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dependent autoreactive responses by NKT cells (Figure 6A),
demonstrating that endosomal recycling of CD1d molecules is not
required for presentation of antigenic cellular lipids. Addition of LPC
to wild-type CD1d transfectants resulted in statistically significant
increases in NKT cell cytokine secretion in three out of 17
experiments (Figure 6B). In these cases, the magnitude of the
enhancement was low (a mean increase of 1.48-fold60.234).
However, addition of LPC to tail-deleted CD1d transfectants
produced significantly enhanced NKT cell responses in seven out
of 19 experiments, and in these cases, the magnitude of the effect was
greater (mean increase of 3.67-fold61.727). These experiments
indicate that it is possible for extracellular LPC to compete with
endogenous ligands and load into cell surface CD1d molecules,
although this pathway does not appear to be highly reproducible.
Additionally, these results suggest that endosomal recycling of CD1d
molecules limits the presentation of extracellular LPC.
To further investigate, we compared two species of LPC. Most
LPC species that have been identified as CD1d cellular ligands
contain carbon chains with one or more double bonds [25,29];
however, the most abundant species of LPC in extracellular fluids is
often the fully saturated C16:0 carbon chain form. We found that
NKT cell responses to APCs pulsed with C18:1 and C16:0 LPC
appeared similar (Figure 6C), suggesting that both species can load
into cell surface CD1d. Importantly, the NKT cell responses to
LPC-treated APCs were completely CD1d-dependent, since the
CD1d-negative parental cell line that was pulsed with LPC did not
stimulate NKT cell cytokine secretion (Figure 6C). Interestingly,
similar to our results using recombinant CD1d-Fc molecules for
presentation, the LPC-dependent responses were highly concentra-
tion dependent and consistently appeared diminished or abrogated
when the APCs were pulsed with high levels of LPC (Figure 6C).
We next tested the effect of blocking phospholipase A2 enzymes
on the autoreactive responses of NKT cells. Human monocytes in
peripheral blood constitutively express CD1d and stimulate
CD1d-dependent cytokine secretion by human NKT cells in the
absence of added antigens [32–34]. We isolated monocytes from
human peripheral blood and preincubated them for 24 h with a
polyclonal preparation of chicken antibodies (IgY) directed against
secreted phospholipase A2 (sPLA2), or with a negative control
preparation of polyclonal IgY [35]. The monocytes were then
washed and used to stimulate cytokine secretion by human NKT
cell clones. Monocytes that were pretreated with the anti-sPLA2
antibody showed significantly reduced stimulation of NKT cell
cytokine secretion compared to those that were treated with the
negative control antibody, or to untreated monocytes (Figure 6D).
Importantly, monocyte cell surface expression of CD1d was not
reduced by anti-sPLA2 antibody pretreatment (unpublished data).
These results point to an important role for PLA2 enzymes, key
producers of LPC in vivo, in the activation of NKT cells by
physiological APCs.
Responses to LPC by Human Peripheral Blood
Lymphocytes
To further investigate the physiological role of LPC presentation
by CD1d, we analyzed IFNc responses by human peripheral
blood lymphocytes (PBLs) directly ex vivo. Lymphocytes were
freshly isolated from ten healthy adult donors, and tested by
ELISpot analysis for cells that produced IFNc in response to
CD1d transfected or untransfected APCs. Because the APCs used
for these experiments do not express MHC class II molecules on
the cell surface and have reduced MHC class I expression [36],
they should not stimulate marked alloreactive responses from the
peripheral blood T cell populations of most donors. Consistent
with this, most donors (seven out of ten) showed little or no IFNc
secretion (i.e., less than 20 spots per well) in response to the
untransfected APCs (Figure 7A, left plot). However, PBL samples
that were incubated with CD1d-transfected APCs consistently
showed significantly increased numbers of spots (Figure 7A, left
plot), suggesting that exposure to APCs expressing CD1d
stimulated lymphocytes within the samples. Notably, the increased
IFNc production did not require the CD1d
+ APCs to be prepulsed
with antigen, suggesting that the responses are due to recognition
of an endogenous antigen. PBL samples that were incubated with
CD1d-transfected APCs prepulsed with C20:2 consistently showed
a further increase in the number of spots (Figure 7A, middle plot),
suggesting that additional T cells were activated by CD1d-
mediated presentation of the a-GalCer analog. Most donors (eight
out of ten) showed increased numbers of spots in response to
CD1d tail-deleted APCs pulsed with LPC, compared to CD1d
tail-deleted APCs treated with vehicle alone (Figure 7A, right plot).
Six of the eight ‘‘responding’’ donors showed marked increases in
the number of spots detected in response to the LPC-pulsed APCs
(Figure 7B). These data suggest that CD1d-restricted T cells that
respond to LPC as an antigen are present in the blood of healthy
human adults.
Discussion
The results presented here show that a fraction of human NKT
cells specifically recognize LPC and LSM. Recognition of these
lipids was observed using NKT cells that express semi-invariant T
cell receptors and recognize a class of foreign antigens called a-
GSLs [23,26]. Semi-invariant NKT cells (or ‘‘iNKT’’ cells) such as
these have been associated with beneficial immunoregulatory
effects in a variety of murine models and also appear deficient in
certain human autoimmune conditions [1–3]. It has been
hypothesized that iNKT cell recognition of self-antigens allows
them to perform immunoregulatory functions without foreign
antigenic stimulation; however, the specific mechanisms by which
this may occur have remained unclear. Our results indicate that
the functions of NKT cells may be regulated by conserved lipid
signaling pathways that operate during normal physiology and
that have elevated activity during pathophysiological processes.
It has recently been shown that LPC can be isolated from
human CD1d molecules purified from human lymphoblastoid cell
lines [25,29], providing strong evidence that lyso-phospholipids
such as LPC can successfully compete with other types of self-lipids
for loading into CD1d molecules. LPC is produced by the action
of PLA2 enzymes, which are a functionally defined superfamily
comprising at least 15 distinct types of proteins that localize to a
variety of intracellular and extracellular sites [37]. Therefore,
multiple sources of LPC may be available for loading into CD1d
mean of the responses. (C) Transfected cells expressing tail-deleted CD1d (CD1d
+ APCs) or the untransfected parent cells (CD1d
2 APCs) were pulsed
with the indicated concentrations of C18:1 or C16:0 LPC, and used to stimulate clone Jc2.7. Similar concentration-dependent LPC responses were
observed in three independent experiments. (D) Freshly isolated human monocytes were incubated for 24 h in culture medium (‘‘untreated’’), or in
culture medium containing anti-sPLA2 IgY or negative control IgY, then washed and used to stimulate cytokine secretion by NKT cell clones J24L.17
and J3N.5. Culture supernatants were analyzed for GM-CSF and IL-13 concentration by ELISA; the plots show the means and standard deviations of
triplicate samples. One representative experiment out of three is shown.
doi:10.1371/journal.pbio.1000228.g006
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cytokines, neurotransmitters, hormones, and other extracellular
signals can lead to the activation of cytoplasmic PLA2 enzymes
and release of LPC into the cytoplasm [38]. Additionally, the
recent identification of a lysosome-resident PLA2 enzyme that is
up-regulated in human monocytic cells upon stimulation through
the retinoid X receptor suggests that LPC is produced within
lysosomes after certain kinds of cellular activation [39]. Finally,
several types of secreted PLA2 enzymes produce LPC by cleaving
PC on the outer leaflet of the plasma membrane [40], and this
LPC could load into CD1d molecules at the cell surface.
Our data indicate that secreted PLA2 enzymes are important for
autoantigenic stimulation of NKT cells, since treatment of
monocytes with an IgY preparation that was raised against
purified sPLA2 protein specifically blocked their subsequent
activation of NKT cells. This finding is consistent with the
possibility that the cell surface is an important site of LPC
production for loading into CD1d molecules. However, it is not
Figure 7. Activation of human peripheral blood lymphocytes. CD1d-transfected or untransfected APCs were pulsed with antigen or treated
with vehicle alone, and then used to stimulate freshly isolated PBLs from ten healthy human donors. The frequency of IFNc-secreting cells in each
sample was assessed by ELISpot analysis. (A) Comparison of the average number of positive spots from triplicate wells of PBLs stimulated with the
following APCs: left plot, untransfected (UT) APCs versus CD1d tail-deleted transfectant (TD.hCD1d) treated with vehicle alone; middle plot, wild-type
CD1d transfectant (WT.hCD1d) treated with either vehicle or C20:2 a-GSL; right plot, tail-deleted CD1d transfectant treated with either vehicle or LPC.
The data were statistically analyzed using a one-tailed Wilcoxon signed-rank t-test, yielding the p-values shown on the plots. (B) Results from
individual donor samples that showed statistically significant increases in IFNc spots in response to APCs treated with LPC. The plots show the mean
numbers of spots detected from untransfected APCs (open bars) or tail-deleted CD1d transfectants (filled bars) that were prepulsed with the
indicated lipid antigens or with vehicle alone. The p-values for responses to CD1d-transfected cells pulsed with LPC versus vehicle alone are as
follows: donor #1 p=0.0027; donor #2 p=0.0096; donor #3 p=0.0302; donor #4 p=0.105; donor #5 p=0.0021; and donor #6 p=0.0021.
doi:10.1371/journal.pbio.1000228.g007
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LPC facilitate the activation of iNKT cells, since we have
consistently found that NKT cells show little response to CD1d-
mediated presentation of LPC when the lipid is added in
concentrations above about 50 mM. The reason for this is
unknown; our binding studies suggest that LPC does bind to
CD1d molecules at these lipid concentrations. Nevertheless, this
failure of high concentrations of LPC to activate NKT cells may
be physiologically significant, since it occurs when either plate-
bound recombinant CD1d-Fc molecules or CD1d-transfected
APCs are used for LPC presentation. We also find that
transfectants expressing wild-type CD1d molecules (which contin-
uously recycle from the cell surface through endosomal compart-
ments and back to the cell surface) show only a limited ability to
present exogenously added LPC, whereas transfectants expressing
tail-deleted CD1d molecules that are deficient in internalization
from the cell surface appear more efficiently able to present
exogenous LPC. This observation suggests that the normal
recycling of CD1d molecules on APCs may limit the presentation
of extracellular LPC. Thus, it remains to be determined whether
autoreactive iNKT cell activation is most effective when LPC is
produced at concentrations and cellular locations that are
associated with normal physiological states or is further enhanced
by elevated extracellular levels of LPC that are associated with
inflammation.
We show here that lymphocytes that produce IFNc in response
to CD1d
+ APCs are consistently present in the peripheral blood of
healthy adult humans, and that for many donors, there is an
increase in the frequency of IFNc-producing cells when the APCs
are prepulsed with LPC. It is not clear whether the LPC-reactive
lymphocytes detected in this analysis are iNKT cells or whether
they belong to a different subset of CD1d-restricted T cells. For
example, blood samples from human multiple myeloma patients
were recently reported to contain elevated frequencies of LPC-
reactive CD1d-restricted T cells [41]. However, the LPC-reactive
T cells from multiple myeloma patients did not utilize the
characteristic T cell receptor of NKT cells and demonstrated
skewed cytokine production, suggesting that they comprise a
distinct CD1d-restricted T cell population [41]. Since LPC
accumulates to greatly increased concentrations in blood and
other bodily fluids in chronic inflammatory conditions such as
multiple myeloma, it is possible that the T cell populations
detected in blood of multiple myeloma patients were specifically
expanded as a result of the disease state. It is not clear whether
these LPC-reactive T cells play a pathogenic or a regulatory role in
multiple myeloma.
Unfortunately, it has been difficult for us to gauge peripheral
blood frequencies of LPC-reactive T cells in healthy donors
because we have not obtained reproducible staining using LPC-
loaded CD1d tetramers. Thus, it is not clear what fraction of the
total iNKT cell population normally recognizes LPC, or what
fraction of the total LPC-reactive T cell population is normally
comprised of iNKT cells. However, our results do clearly
demonstrate that not all iNKT cells recognize LPC. Approxi-
mately 75% of the NKT cell clones tested (eight out of 12) showed
responses to LPC, whereas the remainder did not respond to this
antigen but did respond well to the a-GSL used as a control. The
ability of individual NKT cell clones to respond to LPC was
generally very reproducible, and therefore, the most likely
explanation for the clonal variation is that the TCR b-chain
sequences of some clones permit recognition of this antigen,
whereas other TCR b-chain sequences do not. Since the NKT cell
clones that failed to respond to LPC nevertheless demonstrate
detectable autoreactive responses to CD1d molecules expressed on
APCs ([23], and unpublished data), these results suggest that some
iNKT cells may recognize another, as yet unidentified, endoge-
nous ligand. Alternatively, our results are also consistent with the
possibility that additional autoreactive responses by iNKT cells
result from recognition of very weak agonists that are abundant
constituents of the ligand pools of human CD1d molecules, such as
diacylated glycerophospholipids (e.g., PC, PI, and PE) and
glycosphingolipids such as GM3 [25,29].
It has recently been demonstrated that an autoreactive subset of
noninvariant CD1d-restricted T cells found in mice can recognize
sulfatide, a glycolipid derived from myelin, and that a lyso- form of
sulfatide is more potently antigenic than the diacylated form
[42,43]. Hence, it may be a common finding that lyso-lipid species
are more antigenic for CD1d-restricted T cells than their
diacylated counterparts. Thus, perhaps autoreactive CD1d-
restricted T cells monitor endogenous levels of cleaved lipids. In
this case, oxidizing agents and lipases that generate these
compounds may play a key role in the activation of these natural
T cell populations. This possibility adds a new dimension to
observations that sPLA2 enzymes play important roles, not only in
inflammatory conditions, but also in host defense during microbial
infections [40], since part of the immunological effects of these
enzymes may result from their production of antigens that
stimulate CD1d-restricted T cells. Similarly, the observation that
lyso-phospholipids such as LPC can serve as potent immune
adjuvants that enhance antigen-specific antibody production and
cytotoxic T cell activation raises the possibility that these effects of
LPC may involve the specific activation of NKT cells [44], since
NKT cells are known to potently enhance memory responses by
antigen-specific B cells and T cells [45,46]. Thus, understanding
the role of self-antigens such as LPC in regulating the responses of
human NKT cells and other CD1d-restricted T cell populations
may provide critical new insights into beneficial immune
activation as well as disease pathology.
Materials and Methods
Lipid Antigens
The glycosphingolipid a-GalCer and its OCH and C20:2
structural analogs were synthesized as described previously
[27,47]. Synthetic preparations of the following lipids were
obtained commercially (Matreya or Avanti Polar Lipids): C18:1/
C18:1 phosphatidic acid, C18:1/C18:1 phosphatidylcholine,
C18:1/C18:1 phosphatidylethanolamine, C18:1/C18:1 phospha-
tidylglycerol, C18:1/C18:1 phosphatidylinositol, C18:1/C18:1/
C18:1/C18:1 cardiolipin, sphingomyelin (containing a C18:1 acyl
chain), C18:1 lyso-phosphatidic acid, C18:1 and C16:0 lyso-
phosphatidylcholine, C18:1 lyso-phosphatidylethanolamine,
C18:1 lyso-phosphatidylglycerol, lyso-sphingomyelin, and sphin-
gosine-1-phosphate. Purified preparations of the ganglioside GM3
(from bovine buttermilk) and lyso-phosphatidylcholine (from
chicken eggs) were purchased from Avanti Polar Lipids.
Diacylated lipids were dissolved in DMSO at a concentration of
100 mg/ml and stored frozen at 220uC. Lyso-phospholipids were
dissolved in 50% DMSO/dH2O at a concentration of 400 mg/ml
and stored frozen at 220uC. Lipids were warmed to room
temperature, then sonicated at 60uC in a heated water bath for
20 min before use.
NKT Cells
Human NKT cell clones were established as described
previously [23], and maintained at 37uC with 5% CO2 in the
following culture medium: RPMI 1640; 2 mM L-glutamine;
100 mg/ml penicillin and streptomycin; 10% fetal bovine serum
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(Atlanta Biologicals); supplemented with 400 U/ml recombinant
human IL-2 (Chiron). The NKT cell clones were periodically
restimulated by incubating them with irradiated allogeneic
peripheral blood mononuclear cells (PBMCs) and 30 ng/ml anti-
CD3 monoclonal antibody (mAb) (clone SPVT-3b). Polyclonal
NKT cells were expanded from freshly isolated PBMCs from a
healthy adult donor as follows: monocytes and B lymphocytes were
removed by magnetic depletion using anti-CD14 and anti-CD19
microbeads (Miltenyi Biotec), and the remaining cells were
incubated with human CD1d tetramer loaded with the C20:2
analog of a-GalCer, then the labeled cells were separated using
goat anti-mouse IgG magnetic microbeads (Miltenyi Biotec). The
positively selected cells were stimulated to proliferate by exposure
to irradiated autologous PBMCs, in medium containing 250 ng/
ml PHA-p. Recombinant human IL-2 (Chiron) was added after
2 d at a concentration of 40 U/ml, and titrated up to 400 U/ml
over a period of 10 d. Experiments were performed on the
polyclonal NKT cells within 3–4 wk of the initial sorting from
fresh blood.
CD1d Transfectants
APCs expressing wild-type or tail-deleted CD1d molecules were
generated using the human lymphoblastoid 3023 cell line, as
described previously [22]. The untransfected 3023 parental cell line
was maintained in the following culture medium: RPMI 1640; 2 mM
L-glutamine; 100 mg/ml penicillin and streptomycin; 5% bovine calf
serum (Hyclone); 5% fetal bovine serum (Hyclone); 0.5 mg/ml G418
(Mediatech). For the transfected cell lines, this culture medium was
supplemented with 0.5 mg/ml puromycin (Sigma-Aldrich).
Recombinant CD1d Antigen-Presenting Assay
Recombinant human CD1d-Fc fusion protein was prepared as
previously described [23]. CD1d-Fc fusion protein and anti-CD11a
antibody (clone HI111, BioLegend) were coated onto high protein
binding 96-well microtiter plates at 0.5 mg and 0.05 mg per well,
respectively. Where indicated, the CD1d-Fc was replaced by
human CD1c-Fc fusion protein or an isotype-matched negative
controlantibody(clone UPC-10). The wells werethen incubated for
16–20 h at 37uC with C20:2, OCH, or test lipids diluted in 25%
DMSO/dH2O. The wells were washed with sterile PBS, then
RPMI, then RPMI containing 10% fetal bovine serum, and NKT
cellclones(5610
4/well)wereadded ina final volume of 200 ml/well
in culture medium (RPMI 1640; 2 mM L-glutamine; 100 mg/ml
penicillin and streptomycin; 10% fetal bovine serum (Hyclone);
1 mM sodium pyruvate; 55 mM 2-mercaptoethanol; and nonessen-
tial amino acids). Where indicated, anti-CD1d antibodies (clone
CD1d42.1) or an isotype-matched negative control antibody (clone
P3) were added to the wells at a final concentration of 10 mg/ml,
priorto the additionofNKTcells.Supernatantswere collectedafter
18–24 h, analyzed for granulocyte macrophage colony-stimulating
factor (GM-CSF) by ELISA (BioLegend), and quantified by
comparison to recombinant human GM-CSF standards (Pepro-
Tech). Using this protocol, the means 6 standard deviations of the
background GM-CSF secretion were as follows: NKT cells exposed
to plate-bound anti-CD11a without CD1d-Fc molecules,
47.9688.9 (n=44); NKT cells exposed to plate-bound anti-
CD11a and untreated CD1d-Fc molecules, 44.2667.9 (n=69);
NKT cells exposed to plate-bound anti-CD11a and vehicle-pulsed
CD1d-Fc molecules, 45.2680.2 (n=210).
Lyso-Phospholipid Binding to CD1 Molecules
Lyso-phosphatidylethanolamine (LPE) was biotinylated using
Sulfo-NHS-biotin (Pierce), according to the manufacturer’s
protocol. The biotinylated lipid was dissolved in DMSO at a
concentration of 100 mg/ml and sonicated at 60uC in a heated
water bath for 20 min. Biotinylated LPE in PBS supplemented
with 1 mg/ml BSA was incubated at the indicated concentrations
for 2 h at 37uC with recombinant CD1c-Fc or CD1d-Fc fusion
proteins, or with secreted native CD1d molecules produced in a
human lymphoblastoid cell line as described [25]. The lipid-
treated CD1 molecules were then incubated in microtiter plates
coated with anti-CD1c mAb (clone F10/21A3), anti-CD1d mAb
(clone CD1d42), or an isotype-matched negative control mAb
(clone P3), to allow assessment of the CD1-dependent binding
compared to the background, and biotinylated-LPE was detected
using streptavidin-alkaline phosphatase (Zymed).
Lyso-phospholipid association with CD1d was also tested using
an assay that measures displacement of a charged lipid ligand that
is prebound to the CD1d [48]. A 6-His–tagged construct of the
human CD1d ectodomain was coexpressed with human b2-
microglobulin using a baculovirus insect expression system. CD1d
protein was purified using Ni-NTA resin, followed by size-
exclusion chromatography over a Superdex 200 column (GE
Healthcare). The CD1d was loaded with purified trisialoganglio-
side GT1b (Matreya), as described previously [48]. Untreated or
GT1b-loaded CD1d preparations were incubated for 2 h at 37uC
at a protein concentration of 40 mM in HBS, in the presence of the
indicated concentrations of a-GalCer, C18:1 LPC, C18:1 LPE, or
GT1b as a control. The species were then separated according to
charge on a native isoelectric focusing gel (IEF PhastGel, GE
Healthcare), and protein bands were visualized by Coomassie
stain.
Effects of Prebound Lipids on Antigen Loading
To assess inhibitory effects on antigen presentation, microtiter
plate wells coated with recombinant CD1d-Fc fusion protein and
anti-LFA-1 mAb were incubated for 24 h at 37uC with vehicle
(25% DMSO in dH2O), or with vehicle containing the indicated
lipids at a final concentration of 75 mM. The wells were then
washed with PBS, and a solution of 0.6 mM C20:2 (dissolved in
PBS supplemented with 1 mg/ml BSA) was added and incubated
for 24 h at 37uC. The wells were washed again, and NKT cell
clones (5610
4/well) were added and incubated for 18–20 h at
37uC with 5% CO2. Supernatants were collected and analyzed by
standardized ELISA for GM-CSF concentration. Percent inhibi-
tion was calculated by the following formula: 12(GM-CSF
produced in response to lipid pretreated CD1d/GM-CSF
produced in response to vehicle pretreated CD1d)6100.
Lipid Antigen Presentation by Cell Surface CD1d
Wild-type or tail-deleted CD1d transfected or untransfected
3023 human B lymphoblastoid cells were pulsed for 4 h at 37uC
with a-GalCer, or lyso-phosphatidylcholine (LPC), or vehicle
(DMSO) alone. The cells were washed with culture medium, then
co-incubated at a 1:1 ratio (5610
4/well each) with NKT cells, in a
final volume of 200 ml. Supernatants were collected after 18–24 h,
and analyzed for NKT cell production of GM-CSF using a
standardized ELISA.
PLA2 Blockade
Polyclonal anti-sPLA2 IgY antibodies were prepared by
immunizing Single-Comb White Leghorn laying hens with sPLA2
IB enzyme purified from porcine pancreas (Novozyme) in
complete Freund’s adjuvant (CFA). Negative control IgY antibod-
ies were prepared by immunizing the hens with CFA alone [35].
The two IgY antibody preparations were purified from egg yolks
by extraction with polyethylene glycol, followed by dialysis using a
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of IgY specific for sPLA2 in the immunized antibody preparation
was confirmed by ELISA, whereas the negative control antibody
preparation showed no detectable anti-sPLA2 antibody signal
(Figure S1A). The anti-PLA2 IgY preparation was capable of
reducing the conversion of PC to LPC by a secreted PLA2 enzyme
in vitro, whereas the negative control IgY did not have this effect
(Figure S1B). Additionally, we observed specific binding of the
anti-PLA2 IgY to the cell surface of freshly isolated human
monocytes (Figure S1C), suggesting that antibodies within the
preparation recognize human PLA2 molecules. To assess the effect
of anti-sPLA2 antibody treatment on NKT cell activation,
monocytes were isolated from human PBMC samples by magnetic
sorting using CD14 microbeads (Miltenyi Biotec). The monocytes
were incubated for 18–24 h at 37uC and 5% CO2 in culture
medium containing 20 mg/ml anti-sPLA2 or negative control IgY,
or in culture medium with no added antibodies. The monocytes
were washed with fresh medium and then combined at a 1:1 ratio
with NKT cells (5610
4/well of each). Supernatants were collected
after 24 h and analyzed by ELISA for the production of GM-CSF
and IL-13 (BioLegend).
ELISpot Analysis
Human PBMCs were purified from fresh blood obtained from
healthy adult donors using Ficoll-Paque density gradient centri-
fugation (GE Health Sciences), and B cells, monocytic cells, and
plasmacytoid DCs were removed by magnetic sorting using beads
specific for CD19, CD14, and BDCA-4 (Miltenyi). CD1d
transfected or untransfected 3023 cells were incubated for 2 h at
37uC in culture medium containing LPC (10 mM), or the C20:2
analog of a-GalCer (260 nM), or vehicle (DMSO) alone, then
washed and resuspended in fresh medium. PBMCs and APCs
were added in a 1:1 ratio (100,000 cells per well total) in serum-
free medium (CELLect medium, MP Biomedicals) to triplicate
wells of 96-well PVDF membrane plates (Whatman) coated with
anti-human IFNc mAb (clone NIB42 from BioLegend). The cells
were incubated for 48 h at 37uC and 5% CO2. Secreted IFNc was
detected using biotinylated anti-human IFNc mAb (clone M701B
from Thermo Scientific), and revealed by development with
streptavidin-alkaline phosphatase and BCIP/NBT chromogenic
substrate. Spots were quantitated using AID 5.0 software.
Background signal from analysis of PBMCs without added APCs
was typically less than 20 spots per well.
Supporting Information
Figure S1 Specificity and function of anti-PLA2 IgY
antibody. Polyclonal anti-sPLA2 and negative control IgY
antibodies were prepared by immunizing chickens with purified
sPLA2 IB enzyme in complete Freund’s adjuvant or with adjuvant
alone. (A) Analysis of sPLA2 binding activity by ELISA. Microtiter
plates were coated with purified porcine sPLA2 IB enzyme and
blocked with bovine serum albumin. Dilutions of purified anti-
PLA2 IgY or negative control IgY preparations were added to the
wells, and bound IgY antibody was detected using HRP
conjugated goat anti-IgY antibody. (B) Effect on sPLA2 enzyme
activity. Synthetic C18:1/C18:1 phosphatidylcholine was incubat-
ed in aqueous solution with sPLA2 enzyme purified from bee
venom in the presence of anti-sPLA2 or negative control IgY.
Lipids were extracted using chloroform, then separated by thin
layer chromatography (TLC) on silica gel 60 plates using
chloroform-methanol-glacial acetic acid-water (90:40:12:4 v/v)
and visualized using iodine vapors. Synthetic preparations of LPC
and PC were run in parallel to confirm the relative migration of
the two species. The figure was made from a color photograph of a
TLC plate that was converted to a black and white image. (C)
Binding to human monocytes. Monocytes were isolated from
peripheral blood of healthy human volunteer donors by magnetic
sorting using anti-CD14 microbeads. The purified cells were
incubated with 20 mg/ml anti-sPLA2 or negative control IgY, or
with no primary antibody, then stained with a fluorescently labeled
rabbit anti-IgY second-step antibody, and analyzed by flow
cytometry.
Found at: doi:10.1371/journal.pbio.1000228.s001 (0.40 MB TIF)
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